Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy

26 Mar 2020

Abstract excerpt

INTRODUCTION: Persistent high-risk human papillomavirus infection is the main cause of various types of cancer especially cervical cancer. The E6 and E7 oncoproteins of HPV play critical roles in promoting carcinogenesis and cancer cell growth. As a result, E6 and E7 oncogenes are considered as promising therapeutic targets for cervical cancer. Recently, the development of genome-editing technologies including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Polyomavirus and related diseases
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32281426
DOI: 10.1080/17425247.2020.1747429

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapyPMID 32281426Read ↗

Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatmentSemantic proximity Read ↗

Emerging Therapeutic Strategies for HPV-Related Cancers: From Gene Editing to Precision OncologySemantic proximity Read ↗

Hyperactivation of p53 using CRISPRa kills human papillomavirus driven cervical cancer cellsSemantic proximity Read ↗

The Application of CRISPR/Cas9 System in Cervical Precancerous LesionsSemantic proximity Read ↗

Genome editing via non-viral delivery platforms: current progress in personalized cancer therapySemantic proximity Read ↗

CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.Semantic proximity Read ↗

Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer CellsSemantic proximity Read ↗

Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer CellsSemantic proximity Read ↗

DNA vaccines for cervical cancer: from bench to bedsideSemantic proximity Read ↗

New Advances in Using Virus-like Particles and Related Technologies for Eukaryotic Genome Editing DeliverySemantic proximity Read ↗

Antiproliferative Effects of AAV-Delivered CRISPR/Cas9-Based Degradation of the HPV18-E6 Gene in HeLa CellsSemantic proximity Read ↗

Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.